Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

NCT00004187 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine
DRUG: oxaliplatin

Sponsor

Swiss Cancer Institute